Michael Platten
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated
German Consortium on Aggressive Meningiomas (KAM), Ratliff M, Neidert M, Wirsching H, Harter P, Unterberg A, Herold-Mende C, Jungwirth G, Etminan N, Lamszus K, Westphal M, Hänggi D, Jungk C, Mawrin C, Platten M, Snuderl M, Sahm F, von Deimling A, Preusser M, Weller M, Wick W, Acker T, Reifenberger G, Jones D, Pfister S, Frank S, Hench J, Brandner S, Aldape K, Sen C, Golfinos J, Serrano J, Stein M, Dohmen H, Reuss D, Dogan H, Patel A, Blume C, Euskirchen P, Sill M, Schrimpf D, Berghoff A, Sievers P, Hielscher T, Stichel D, Reinhardt A, Suwala A, Grady C, Jones T, Bridges L, Greenway F, Leu S, Jaunmuktane Z, Schittenhelm J, Ketter R, Bewerunge-Hudler M, Rushing E, Ricklefs F, Baumgarten P, Wefers A, Maas S. Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated. J Clin Oncol 2021; 39:3839-3852.
07.10.2021Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated
07.10.2021J Clin Oncol 2021; 39:3839-3852
German Consortium on Aggressive Meningiomas (KAM), Ratliff Miriam, Neidert Marian Christoph, Wirsching Hans-Georg, Harter Patrick N, Unterberg Andreas, Herold-Mende Christel, Jungwirth Gerhard, Etminan Nima, Lamszus Katrin, Westphal Manfred, Hänggi Daniel, Jungk Christine, Mawrin Christian, Platten Michael, Snuderl Matija, Sahm Felix, von Deimling Andreas, Preusser Matthias, Weller Michael, Wick Wolfgang, Acker Till, Reifenberger Guido, Jones David T W, Pfister Stefan M, Frank Stephan, Hench Jürgen, Brandner Sebastian, Aldape Kenneth D, Sen Chandra, Golfinos John, Serrano Jonathan, Stein Marco, Dohmen Hildegard, Reuss David, Dogan Helin, Patel Areeba, Blume Christina, Euskirchen Philipp, Sill Martin, Schrimpf Daniel, Berghoff Anna S, Sievers Philipp, Hielscher Thomas, Stichel Damian, Reinhardt Annekathrin, Suwala Abigail K, Grady Conor, Jones Timothy, Bridges Leslie R, Greenway Fay E A, Leu Severina, Jaunmuktane Zane, Schittenhelm Jens, Ketter Ralf, Bewerunge-Hudler Melanie, Rushing Elisabeth J, Ricklefs Franz, Baumgarten Peter, Wefers Annika K, Maas Sybren L N
Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
Wick W, Golfinopoulos V, Frenel J, Campone M, Ricard D, Marosi C, Villa S, Weyerbrock A, Hopkins K, Homicsko K, Lhermitte B, Pesce G, Roth P, Stupp R, Gorlia T, Bady P, Platten M, van den Bent M, Taphoorn M, Steuve J, Brandes A, Hamou M, Wick A, Kosch M, Weller M, Hegi M. Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082). Clin Cancer Res 2016; 22:4797-4806.
03.05.2016Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
03.05.2016Clin Cancer Res 2016; 22:4797-4806
Wick Wolfgang, Golfinopoulos Vassilis, Frenel Jean-Sebastien, Campone Mario, Ricard Damien, Marosi Christine, Villa Salvador, Weyerbrock Astrid, Hopkins Kirsten, Homicsko Krisztian, Lhermitte Benoit, Pesce Gianfranco, Roth Patrick, Stupp Roger, Gorlia Thierry, Bady Pierre, Platten Michael, van den Bent Martin J, Taphoorn Martin J B, Steuve Jonathan, Brandes Alba A, Hamou Marie-France, Wick Antje, Kosch Markus, Weller Michael, Hegi Monika E